RESEARCHER PROFILE

Frédéric Bibeau

← Back to Université Marie et Louis Pasteur

F

Université Marie et Louis Pasteur

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsGenetic factors in colorectal cancerBreast Cancer Treatment StudiesHER2/EGFR in Cancer Research

Frédéric Bibeau works in Colorectal Cancer Treatments and Studies, Colorectal Cancer Surgical Treatments, Genetic factors in colorectal cancer, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research. Recorded institutional associations include Inserm, Centre Hospitalier Universitaire de Besançon, Fédération Francophone de Cancérologie Digestive.

515Publications
17,014Citations
64H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

    2008 · 1,444 citations
  2. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

    2019 · 1,041 citations
  3. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

    2014 · 678 citations
  4. Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

    2009 · 663 citations
  5. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

    2009 · 623 citations
  6. Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan

    2009 · 521 citations
  7. Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium

    2007 · 494 citations
  8. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research

    2019 · 372 citations
  9. Oestrogen receptor negative breast cancers exhibit high cytokine content

    2007 · 349 citations
  10. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei

    2017 · 308 citations
  11. A refined molecular taxonomy of breast cancer

    2011 · 287 citations
  12. The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the “DISTANCE”?

    2013 · 264 citations
  13. Snail and Slug Play Distinct Roles during Breast Carcinoma Progression

    2006 · 259 citations
  14. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status

    2018 · 248 citations
  15. Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer

    2009 · 243 citations
  16. Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

    2005 · 234 citations
  17. Gene Expression Signature in Advanced Colorectal Cancer Patients Select Drugs and Response for the Use of Leucovorin, Fluorouracil, and Irinotecan

    2007 · 210 citations
  18. A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer

    2008 · 203 citations
  19. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

    2021 · 202 citations
  20. Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer

    2013 · 190 citations
  21. Impact of RNA degradation on gene expression profiles: Assessment of different methods to reliably determine RNA quality

    2006 · 182 citations
  22. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan‐treated metastases

    2004 · 180 citations
  23. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS)

    2016 · 176 citations
  24. Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care

    2016 · 171 citations
  25. Is cancer biology different in older patients?

    2021 · 161 citations

← Return to the university profile